SYRE — SPYRE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 277 SEC-registered investment managers reported holding SYRE (SPYRE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $8.97B across 103.70M shares. That is +21.7% by share count (+16.38M shares) versus the previous quarter, while reported value moved +112.3%. Ownership is concentrated: the five largest holders account for 31.6% of reported value and the top ten for 46.4%.
Compared with the prior quarter, 96 opened new positions, 105 added to existing stakes, 59 trimmed, 23 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of SPYRE THERAPEUTICS INC (SYRE) include Fidelity Management & Research (FMR), BlackRock Inc, PERCEPTIVE ADVISORS LLC, ranked by reported 13F value among the 419 institutional holders on this page.
SYRE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding SYRE
The superinvestors we track who report SYRE in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 786.92K | $14.48M | 0.08% | New |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 202 | 59.59M | $5.05B | +10.3% |
| Q2 2026 | 277 | 103.70M | $8.97B | +21.7% |
| Q1 2026 | 204 | 87.63M | $4.33B | +1.6% |
| Q4 2025 | 159 | 85.39M | $2.74B | +23.1% |
| Q3 2025 | 142 | 67.66M | $1.12B | -0.9% |
| Q2 2025 | 133 | 66.88M | $987.32M | +2.7% |
| Q1 2025 | 131 | 64.45M | $1.04B | -0.3% |
| Q4 2024 | 131 | 61.62M | $1.42B | +15.2% |
Over the 8 quarters shown, institutional share counts decreased 3% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+23.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.50M | $1.20B | 0.06% | Add | |
| 7.46M | $616.09M | 0.01% | Add | |
| 4.13M | $363.03M | 0.02% | Add | |
| 4.16M | $341.44M | 0.01% | Add | |
| 3.71M | $317.76M | 0.01% | Add | |
| 2.80M | $240.93M | 0.01% | Add | |
| 2.36M | $210.47M | 0.03% | Add | |
| 1.82M | $148.58M | 0.03% | Add | |
| 1.73M | $146.91M | 0.02% | Add | |
| 1.28M | $113.88M | 5.30% | Hold | |
| 1.16M | $103.33M | 37.77% | Reduce | |
| 883.90K | $78.69M | 0.26% | New | |
| 868.60K | $77.33M | 1.84% | Reduce | |
| 911.01K | $76.09M | 0.03% | Add | |
| 630.41K | $56.13M | 0.01% | Reduce | |
| 602.52K | $53.64M | 0.05% | New | |
| 651.71K | $53.48M | 0.01% | Add | |
| 599.22K | $53.35M | 0.07% | New | |
| 571.05K | $50.84M | 1.40% | Add | |
| 548.67K | $48.85M | 0.03% | Reduce | |
| 544.13K | $48.44M | 0.08% | Reduce | |
| 514.89K | $45.84M | 0.02% | New | |
| 479.13K | $42.66M | 0.04% | Reduce | |
| 448.57K | $40.08M | 0.18% | Reduce | |
| 366.13K | $32.60M | 1.33% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.78M | $594.23M | 0.03% | Add | |
| 5.52M | $278.49M | 0.01% | Hold | |
| 4.17M | $210.44M | 2.09% | Hold | |
| 4.02M | $202.67M | 14.64% | Hold | |
| 3.78M | $190.83M | 4.01% | Add | |
| 3.69M | $185.89M | 6.94% | Hold | |
| 3.06M | $154.22M | 0.00% | New | |
| 2.79M | $140.77M | 1.03% | Reduce | |
| 2.61M | $131.50M | 0.01% | Add | |
| 1.96M | $98.72M | 2.02% | Add | |
| 1.91M | $96.46M | 5.58% | Reduce | |
| 1.90M | $95.87M | 2.74% | Hold | |
| 1.89M | $95.44M | 4.85% | Hold | |
| 1.82M | $92.04M | 0.02% | Add | |
| 1.82M | $92.04M | 0.02% | Add | |
| 1.75M | $88.07M | 0.02% | Reduce | |
| 1.72M | $86.82M | 0.01% | Add | |
| 1.66M | $83.59M | 0.04% | Reduce | |
| 1.62M | $81.79M | 0.87% | Hold | |
| 1.60M | $80.64M | 0.01% | Hold | |
| 1.46M | $73.45M | 26.13% | Hold | |
| 1.28M | $64.52M | 3.47% | Reduce | |
| 1.23M | $61.95M | 0.01% | Add | |
| 1.00M | $50.44M | 0.30% | Hold | |
| 932.82K | $47.05M | 1.78% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.64M | $381.29M | 0.02% | Add | |
| 5.52M | $180.90M | 0.01% | Add | |
| 4.17M | $136.67M | 1.37% | Add | |
| 4.04M | $132.19M | 0.00% | Add | |
| 4.02M | $131.63M | 10.02% | Hold | |
| 3.69M | $120.74M | 5.96% | Add | |
| 3.49M | $114.42M | 0.02% | Add | |
| 3.07M | $100.55M | 1.90% | Add | |
| 2.88M | $94.43M | 0.64% | Add | |
| 2.39M | $78.24M | 5.21% | Add | |
| 2.26M | $74.13M | 0.00% | Add | |
| 1.90M | $62.26M | 2.06% | Add | |
| 1.89M | $61.99M | 3.06% | Reduce | |
| 1.83M | $59.92M | 0.03% | Add | |
| 1.66M | $54.36M | 0.00% | Add | |
| 1.63M | $53.55M | 1.83% | Reduce | |
| 1.62M | $53.12M | 0.54% | New | |
| 1.60M | $52.48M | 0.01% | Add | |
| 1.55M | $50.75M | 0.01% | Reduce | |
| 1.55M | $50.75M | 0.01% | Reduce | |
| 1.47M | $48.07M | 1.23% | Hold | |
| 1.46M | $47.71M | 28.03% | New | |
| 1.43M | $46.93M | 2.86% | Add | |
| 1.11M | $36.34M | 0.01% | Add | |
| 1.00M | $32.76M | 0.20% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.06M | $151.85M | 0.01% | Hold | |
| 4.02M | $67.34M | 6.06% | Hold | |
| 3.98M | $66.75M | 0.00% | Reduce | |
| 3.62M | $60.70M | 0.75% | Hold | |
| 3.20M | $53.63M | 2.06% | Hold | |
| 3.05M | $51.13M | 0.00% | Reduce | |
| 2.69M | $45.01M | 2.53% | Hold | |
| 2.58M | $43.21M | 1.36% | Hold | |
| 2.39M | $40.10M | 0.01% | Hold | |
| 2.06M | $34.53M | 0.25% | Reduce | |
| 1.99M | $33.32M | 1.63% | Hold | |
| 1.79M | $29.92M | 0.00% | Add | |
| 1.64M | $27.49M | 0.01% | Add | |
| 1.64M | $27.49M | 0.01% | Add | |
| 1.47M | $24.59M | 0.82% | Reduce | |
| 1.42M | $23.79M | 2.29% | Add | |
| 1.39M | $23.28M | 0.28% | Hold | |
| 1.23M | $20.61M | 0.62% | Reduce | |
| 1.23M | $20.54M | 0.00% | Hold | |
| 1.10M | $18.45M | 0.91% | New | |
| 1.04M | $17.37M | 0.02% | Reduce | |
| 1.00M | $16.76M | 0.12% | Add | |
| 795.27K | $13.33M | 0.00% | Hold | |
| 788.79K | $13.22M | 0.07% | Add | |
| 620.62K | $10.40M | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.05M | $135.52M | 0.01% | Hold | |
| 4.02M | $60.15M | 7.79% | Hold | |
| 4.01M | $59.99M | 0.00% | Add | |
| 3.62M | $54.22M | 0.77% | Hold | |
| 3.20M | $47.90M | 2.42% | Add | |
| 3.07M | $45.91M | 0.00% | Add | |
| 2.69M | $40.20M | 3.01% | Hold | |
| 2.58M | $38.60M | 1.52% | Hold | |
| 2.39M | $35.82M | 0.01% | Hold | |
| 2.09M | $31.22M | 0.25% | Reduce | |
| 1.99M | $29.76M | 2.10% | Hold | |
| 1.87M | $28.00M | 1.20% | Reduce | |
| 1.60M | $23.88M | 0.00% | Reduce | |
| 1.53M | $22.90M | 0.85% | Reduce | |
| 1.51M | $22.66M | 0.01% | Reduce | |
| 1.51M | $22.66M | 0.00% | Reduce | |
| 1.39M | $20.79M | 0.43% | Add | |
| 1.23M | $18.37M | 0.00% | Add | |
| 1.08M | $16.16M | 0.02% | Add | |
| 930.48K | $13.93M | 0.00% | Add | |
| 795.27K | $11.91M | 0.00% | Add | |
| 745.00K | $11.15M | 0.06% | Reduce | |
| 671.04K | $10.05M | 0.00% | Add | |
| 626.70K | $9.38M | 0.09% | New | |
| 613.66K | $9.19M | 0.18% | Add |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.56M sh · $239.26M
- Jupiter Topco LLC 2.21M sh · $195.88M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 1.72M sh · $152.91M
- Holocene Advisors, LP 1.02M sh · $90.13M
- Sixth Street Partners Management Company, L.P. 652.96K sh · $57.97M
- Integral Health Asset Management, LLC 325.00K sh · $28.85M
- JENNISON ASSOCIATES LLC 303.18K sh · $26.92M
- Bellevue Group AG 229.93K sh · $20.41M
- Cormorant Asset Management, LP 225.00K sh · $19.98M
- EVENTIDE ASSET MANAGEMENT, LLC 201.62K sh · $17.90M
- ORBIMED ADVISORS LLC 186.15K sh · $16.53M
- FRONTIER CAPITAL MANAGEMENT CO LLC 182.93K sh · $16.24M
Fully Exited (vs previous quarter)
- Fairmount Funds Management LLC sold 4.02M sh · $202.67M
- STATE STREET CORP sold 2.61M sh · $131.50M
- Janus Henderson Group sold 1.66M sh · $83.59M
- RA CAPITAL MANAGEMENT, L.P. sold 1.62M sh · $81.79M
- BAKER BROS. ADVISORS LP sold 1.00M sh · $50.44M
- Caligan Partners LP sold 878.13K sh · $44.29M
- ExodusPoint Capital Management, LP sold 87.06K sh · $4.39M
- ALPS ADVISORS INC sold 63.94K sh · $3.23M
- Assenagon Asset Management S.A. sold 18.65K sh · $940.55K
- Carlyle Group Inc. sold 9.62K sh · $485.23K
- RWC Asset Management LLP sold 8.17K sh · $411.89K
- CAPSTONE INVESTMENT ADVISORS, LLC sold 7.54K sh · $380.17K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 13.50M | 13.03M | 11.78M | 11.64M | 9.06M | 9.05M | 9.04M | 8.80M | 7.62M | 7.51M | 6.58M | 3.79M | — |
| BlackRock Inc | 7.46M | 6.51M | 5.52M | 5.52M | 3.98M | 4.01M | 3.57M | 3.40M | 2.66M | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.13M | 2.33M | 585.13K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.16M | 3.45M | 3.06M | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 3.71M | — | 2.61M | 2.26M | 1.79M | 1.60M | 1.70M | 1.68M | 1.54M | 1.41M | 134.43K | — | — |
| Geode Capital Management | 2.80M | 2.56M | 1.72M | 1.66M | 1.23M | 1.23M | 1.06M | 966.13K | 891.05K | 765.83K | 330.23K | 30.33K | 26.80K |
| Capital World Investors | 2.36M | 2.32M | 666.56K | 200.17K | 200.17K | 350.77K | 350.77K | 378.57K | — | — | — | — | — |
| Franklin Resources | 1.82M | 1.47M | 882.83K | 1.11M | 795.27K | 795.27K | 760.63K | 760.64K | 760.67K | 741.90K | 741.90K | 687.09K | — |
| JPMorgan Chase & Co | 1.73M | 1.09M | 979.30K | 62.95K | 275.98K | 47.28K | 41.56K | 35.25K | 29.47K | 22.77K | 11 | 41 | 41 |
| Affinity Asset Advisors, LLC | 1.28M | 1.28M | 1.28M | 1.43M | 1.42M | 606.68K | 481.68K | 824.33K | 498.42K | 513.42K | 410.00K | 517.55K | 242.30K |
| Remedium Capital Partners, LLC | 1.16M | 1.46M | 1.46M | 1.46M | — | — | — | — | — | — | — | — | — |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 883.90K | — | — | — | — | — | — | — | — | — | — | — | — |
| Siren, L.L.C. | 868.60K | 968.60K | 818.60K | 818.60K | 368.60K | 368.60K | 368.60K | 374.00K | — | — | — | — | — |
| UBS Group AG | 911.01K | 843.07K | 671.24K | 680.57K | 385.59K | 462.86K | 552.24K | 392.20K | 57.84K | 44.50K | 2.60K | 3.73K | — |
| Capital International Investors | 630.41K | 955.20K | 1.75M | 3.49M | 2.39M | 2.39M | 2.39M | — | — | — | — | — | — |
| Clearbridge Investments, LLC | 602.52K | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 651.71K | 551.39K | 464.65K | — | — | — | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 599.22K | — | 18.65K | 22.14K | 22.14K | 22.14K | 22.73K | 22.65K | 1.14M | — | 64.40K | — | — |
| EMERALD ADVISERS, LLC | 571.05K | 567.43K | 613.37K | 636.11K | 548.71K | 565.86K | 547.83K | 546.79K | 292.57K | — | — | — | — |
| VICTORY CAPITAL MANAGEMENT INC | 548.67K | 553.98K | 292.13K | 146.08K | 326.08K | 354.12K | 251.85K | 268.08K | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SYRE?
As of 2026-Q2, 277 institutional funds reported holding SYRE (SPYRE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $8.97B.
How many shares of SYRE do institutions own?
13F filers reported 103.70M shares of SYRE, worth $8.97B in aggregate at the end of 2026-Q2.
Is institutional ownership of SYRE rising or falling?
Share counts moved +21.7% versus the prior quarter — accumulation.
Who are the top institutional holders of SYRE?
The largest 13F holders are Fidelity Management & Research (FMR), BlackRock Inc, PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, VANGUARD PORTFOLIO MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of SPYRE THERAPEUTICS INC?
The major shareholders of SPYRE THERAPEUTICS INC (SYRE) by reported 13F value are Fidelity Management & Research (FMR), BlackRock Inc, PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, VANGUARD PORTFOLIO MANAGEMENT LLC, among 419 institutional holders.
Which legendary investors own SYRE?
1 of the legendary investors tracked on HoldingsHub report SYRE (SPYRE THERAPEUTICS INC) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on SYRE?
1 tracked superinvestors hold SYRE simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.